help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zitzmann, M.
Right arrow Articles by Nieschlag, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zitzmann, M.
Right arrow Articles by Nieschlag, E.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 12 6208-6217
Copyright © 2004 by The Endocrine Society

X-Chromosome Inactivation Patterns and Androgen Receptor Functionality Influence Phenotype and Social Characteristics as Well as Pharmacogenetics of Testosterone Therapy in Klinefelter Patients

Michael Zitzmann, Marion Depenbusch, Jörg Gromoll and Eberhard Nieschlag

Institute of Reproductive Medicine, University of Munster, D-48129 Munster, Germany

Address all correspondence and requests for reprints to: Dr. E. Nieschlag, Institute of Reproductive Medicine, University of Munster, Domagkstrasse 11, D-48129 Munster, Germany. E-mail: nieschl{at}uni-muenster.de.

Klinefelter syndrome is characterized by a vast range of phenotypes related to androgen effects. Testosterone (T) acts via the X-linked androgen receptor gene carrying the CAG repeat (CAGn) polymorphism, the length of which is inversely associated with androgen action and might account for the marked variation in phenotypes. In 77 newly diagnosed and untreated Klinefelter patients with a 47,XXY karyotype we assessed phenotype and social traits in relation to X-weighted biallelic CAGn length using X-chromosome inactivation analysis after digestion of leukocyte DNA with methylation-sensitive HpaII. Forty-eight men were hypogonadal and received T substitution therapy; in these, pharmacogenetic effects were investigated. The shorter CAGn allele was preferentially inactive. CAGn length was positively associated with body height. Bone density and the relation of arm span to body height were inversely related to CAGn length. The presence of long CAGn was predictive for gynecomastia and smaller testes, whereas short CAGn were associated with a stable partnership and professions requiring higher standards of education also when corrected for family background. There was a trend for men with longer CAGn to be diagnosed earlier in life. Under T substitution, men with shorter CAGn exhibited a more profound suppression of LH levels, augmented prostate growth, and higher hemoglobin concentrations. A significant genotype-phenotype association exists in Klinefelter patients: androgen effects on appearance and social characteristics are modulated by the androgen receptor CAGn polymorphism. The effects of T substitution are pharmacogenetically modified. This finding is magnified by preferential inactivation of the more functional short CAGn allele.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Zitzmann and E. Nieschlag
Androgen Receptor Gene CAG Repeat Length and Body Mass Index Modulate the Safety of Long-Term Intramuscular Testosterone Undecanoate Therapy in Hypogonadal Men
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3844 - 3853.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Vorona, M. Zitzmann, J. Gromoll, A. N. Schuring, and E. Nieschlag
Clinical, Endocrinological, and Epigenetic Features of the 46,XX Male Syndrome, Compared with 47,XXY Klinefelter Patients
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3458 - 3465.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wang, P. Christenson, and R. Swerdloff
Clinical Relevance of Racial and Ethnic Differences in Sex Steroids
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2433 - 2435.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Zitzmann, S. Faber, and E. Nieschlag
Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4335 - 4343.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Itti, I. T. Gaw Gonzalo, A. Pawlikowska-Haddal, K. B. Boone, A. Mlikotic, L. Itti, F. S. Mishkin, and R. S. Swerdloff
The Structural Brain Correlates of Cognitive Deficits in Adults with Klinefelter's Syndrome
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1423 - 1427.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. Aksglaede, A. M. Wikstrom, E. R.-D. Meyts, L. Dunkel, N. E. Skakkebaek, and A. Juul
Natural history of seminiferous tubule degeneration in Klinefelter syndrome
Hum. Reprod. Update, January 1, 2006; 12(1): 39 - 48.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. R. Zinn, P. Ramos, F. F. Elder, K. Kowal, C. Samango-Sprouse, and J. L. Ross
Androgen Receptor CAGn Repeat Length Influences Phenotype of 47,XXY (Klinefelter) Syndrome
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5041 - 5046.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Lue, J. D. Jentsch, C. Wang, P. N. Rao, A. P. Sinha Hikim, W. Salameh, and R. S. Swerdloff
XXY Mice Exhibit Gonadal and Behavioral Phenotypes Similar to Klinefelter Syndrome
Endocrinology, September 1, 2005; 146(9): 4148 - 4154.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society